Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 175

1.

The Role of Angiogenesis and Pro-Angiogenic Exosomes in Regenerative Dentistry.

Zimta AA, Baru O, Badea M, Buduru SD, Berindan-Neagoe I.

Int J Mol Sci. 2019 Jan 18;20(2). pii: E406. doi: 10.3390/ijms20020406. Review.

2.

Targeting Hedgehog signaling pathway: Paving the road for cancer therapy.

Salaritabar A, Berindan-Neagoe I, Darvish B, Hadjiakhoondi F, Manayi A, Devi KP, Barreca D, Orhan IE, Süntar I, Farooqi AA, Gulei D, Nabavi SF, Sureda A, Daglia M, Dehpour AR, Nabavi SM, Shirooie S.

Pharmacol Res. 2019 Jan 11;141:466-480. doi: 10.1016/j.phrs.2019.01.014. [Epub ahead of print] Review.

PMID:
30639373
3.

CRISPR-based RNA editing: diagnostic applications and therapeutic options.

Gulei D, Raduly L, Berindan-Neagoe I, Calin GA.

Expert Rev Mol Diagn. 2019 Feb;19(2):83-88. doi: 10.1080/14737159.2019.1568242. Epub 2019 Jan 21. No abstract available.

PMID:
30632384
4.

The Potential of Different Origin Stem Cells in Modulating Oral Bone Regeneration Processes.

Buduru SD, Gulei D, Zimta AA, Tigu AB, Cenariu D, Berindan-Neagoe I.

Cells. 2019 Jan 8;8(1). pii: E29. doi: 10.3390/cells8010029. Review.

5.

miR-181a/b therapy in lung cancer: reality or myth?

Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe I.

Mol Oncol. 2019 Jan;13(1):9-25. doi: 10.1002/1878-0261.12420. Epub 2019 Jan 3. Review.

6.

Securidaca-saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells.

Obasi TC, Braicu C, Iacob BC, Bodoki E, Jurj A, Raduly L, Oniga I, Berindan-Neagoe I, Oprean R.

Cancer Manag Res. 2018 Nov 15;10:5709-5724. doi: 10.2147/CMAR.S163328. eCollection 2018. Erratum in: Cancer Manag Res. 2019 Jan 15;11:691.

7.

Next-generation sequencing-based characterization of the invasion by anatomical contiguity in a primary osseous diffuse large B-cell lymphoma. Correlation between the genetic profile of the malignancy and the clinical outcome of the patient.

Zaharie F, Pop LA, Petrushev B, Jurj A, Muresan MS, Eniu D, Fetica B, Petkov B, Pasca S, Piciu D, Rus I, Deak D, Dima D, Desmirean MS, Tomuleasa C, Berindan-Neagoe I.

Histol Histopathol. 2018 Nov 23:18067. doi: 10.14670/HH-18-067. [Epub ahead of print]

PMID:
30467824
8.

Aberrant miRNAs expressed in HER-2 negative breast cancers patient.

Braicu C, Raduly L, Morar-Bolba G, Cojocneanu R, Jurj A, Pop LA, Pileczki V, Ciocan C, Moldovan A, Irimie A, Eniu A, Achimas-Cadariu P, Paradiso A, Berindan-Neagoe I.

J Exp Clin Cancer Res. 2018 Oct 20;37(1):257. doi: 10.1186/s13046-018-0920-2.

9.

Molecular Responses of Cancers by Natural Products: Modifications of Autophagy Revealed by Literature Analysis.

Yeung AWK, El-Demerdash A, Berindan-Neagoe I, Atanasov AG, Ho YS.

Crit Rev Oncog. 2018;23(5-6):347-370. doi: 10.1615/CritRevOncog.2018027566.

PMID:
30311565
10.

Mesenchymal stem cells in myeloproliferative disorders - focus on primary myelofibrosis.

Selicean SE, Tomuleasa C, Grewal R, Almeida-Porada G, Berindan-Neagoe I.

Leuk Lymphoma. 2018 Oct 2:1-10. doi: 10.1080/10428194.2018.1516881. [Epub ahead of print]

PMID:
30277128
11.

The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge.

Temian DC, Pop LA, Irimie AI, Berindan-Neagoe I.

J Breast Cancer. 2018 Sep;21(3):233-243. doi: 10.4048/jbc.2018.21.e41. Epub 2018 Sep 20. Review.

12.

Exosomes at a glance - common nominators for cancer hallmarks and novel diagnosis tools.

Gulei D, Petrut B, Tigu AB, Onaciu A, Fischer-Fodor E, Atanasov AG, Ionescu C, Berindan-Neagoe I.

Crit Rev Biochem Mol Biol. 2018 Oct;53(5):564-577. doi: 10.1080/10409238.2018.1508276. Epub 2018 Sep 24.

PMID:
30247075
13.

Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome.

Jurj A, Pop L, Petrushev B, Pasca S, Dima D, Frinc I, Deak D, Desmirean M, Trifa A, Fetica B, Gafencu G, Selicean S, Moisoiu V, Micu WT, Berce C, Sacu A, Moldovan A, Colita A, Bumbea H, Tanase A, Dascalescu A, Zdrenghea M, Stiufiuc R, Leopold N, Tetean R, Burzo E, Tomuleasa C, Berindan-Neagoe I.

Crit Rev Clin Lab Sci. 2018 Nov;55(7):501-515. doi: 10.1080/10408363.2018.1499707. Epub 2018 Sep 21.

PMID:
30238808
14.

Correction: Genetically enhanced T lymphocytes and the intensive care unit.

Tat T, Li H, Constantinescu CS, Onaciu A, Chira S, Osan C, Pasca S, Petrushev B, Moisoiu V, Micu WT, Berce C, Tranca S, Dima D, Berindan-Neagoe I, Shen J, Tomuleasa C, Qian L.

Oncotarget. 2018 Aug 10;9(62):32097. doi: 10.18632/oncotarget.25983. eCollection 2018 Aug 10.

15.

OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers.

Monroig-Bosque PDC, Shah MY, Fu X, Fuentes-Mattei E, Ling H, Ivan C, Nouraee N, Huang B, Chen L, Pileczki V, Redis RS, Jung EJ, Zhang X, Lehrer M, Nagvekar R, Mafra ACP, Monroig-Bosque MDM, Irimie A, Rivera C, Dan Dumitru C, Berindan-Neagoe I, Nikonowicz EP, Zhang S, Calin GA.

Sci Rep. 2018 Aug 30;8(1):13106. doi: 10.1038/s41598-018-30989-3.

16.

Combined Therapy in Cancer: The Non-coding Approach.

Gulei D, Berindan-Neagoe I.

Mol Ther Nucleic Acids. 2018 Sep 7;12:787-792. doi: 10.1016/j.omtn.2018.07.013. Epub 2018 Jul 31. No abstract available.

17.

Phytol: A review of biomedical activities.

Islam MT, Ali ES, Uddin SJ, Shaw S, Islam MA, Ahmed MI, Chandra Shill M, Karmakar UK, Yarla NS, Khan IN, Billah MM, Pieczynska MD, Zengin G, Malainer C, Nicoletti F, Gulei D, Berindan-Neagoe I, Apostolov A, Banach M, Yeung AWK, El-Demerdash A, Xiao J, Dey P, Yele S, Jóźwik A, Strzałkowska N, Marchewka J, Rengasamy KRR, Horbańczuk J, Kamal MA, Mubarak MS, Mishra SK, Shilpi JA, Atanasov AG.

Food Chem Toxicol. 2018 Nov;121:82-94. doi: 10.1016/j.fct.2018.08.032. Epub 2018 Aug 18.

PMID:
30130593
18.

Premature senescence activation in DLD-1 colorectal cancer cells through adjuvant therapy to induce a miRNA profile modulating cellular death.

Chira S, Raduly L, Braicu C, Jurj A, Cojocneanu-Petric R, Pop L, Pileczki V, Ionescu C, Berindan-Neagoe I.

Exp Ther Med. 2018 Aug;16(2):1241-1249. doi: 10.3892/etm.2018.6324. Epub 2018 Jun 19.

19.

Differential Effect of Smoking on Gene Expression in Head and Neck Cancer Patients.

Irimie AI, Braicu C, Cojocneanu R, Magdo L, Onaciu A, Ciocan C, Mehterov N, Dudea D, Buduru S, Berindan-Neagoe I.

Int J Environ Res Public Health. 2018 Jul 23;15(7). pii: E1558. doi: 10.3390/ijerph15071558.

20.

Overview upon miR-21 in lung cancer: focus on NSCLC.

Bica-Pop C, Cojocneanu-Petric R, Magdo L, Raduly L, Gulei D, Berindan-Neagoe I.

Cell Mol Life Sci. 2018 Oct;75(19):3539-3551. doi: 10.1007/s00018-018-2877-x. Epub 2018 Jul 20. Review.

PMID:
30030592

Supplemental Content

Loading ...
Support Center